Monoglyceride Lipase (MGLL) (Middle Region) Peptide
Quick Overview for Monoglyceride Lipase (MGLL) (Middle Region) Peptide (ABIN8105757)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- Mgll Peptide - middle region
-
Sequence
- PKALIFVSHG AGEHCGRYDE LAQMLKRLDM LVFAHDHVGH GQSEGERMVV
-
-
Monoglyceride Lipase (MGLL) peptide
MGLL Reactivity: Human, Rat, Mouse, Cow, Dog, Pig Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-Mgll Antibody (ARP52322_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MGLL (Monoglyceride Lipase (MGLL))
-
Background
-
Background Information: Mgll converts monoacylglycerides to free fatty acids and glycerol. Mgll hydrolyzes the endocannabinoid 2-arachidonoylglycerol, and thereby contributes to the regulation of endocannabinoid signaling, nociperception and perception of pain. It regulates the levels of fatty acids that serve as signaling molecules and promote cancer cell migration, invasion and tumor growth.
Alternative Symbols: MAGL
-
Molecular Weight
- 33kDa
-
Gene ID
- 29254
-
NCBI Accession
- NP_612511
-
UniProt
- Q8R431
Target
-
